CAJ | 학술논문

目的：观察注射用血栓通联合胞二磷胆碱治疗急性脑梗塞的临床疗效。方法：将120例急性脑梗塞患者随机分为2组，治疗组60例，给予注射用血栓通500 mg加入0.9％氯化钠注射液250 mL，胞二磷胆碱0.75 g加入5％葡萄糖注射液250 mL，静脉滴注，1次/d，疗程14天；对照组60例，给予胞二磷胆碱0.75 g加入5％葡萄糖注射液250 mL，静脉滴注，1次/d，疗程14天。比较治疗前、后症状改善及神经功能缺损评分情况。结果：总有效率治疗组为96.00%，对照组为80.00%，2组比较差异有统计学意义(P＜0.05）。神经功能缺损评分治疗组改善较对照组明显(P＜0.05）。结论：注射用血栓通联合胞二磷胆碱注射液治疗急性脑梗死临床疗效显著。
목적：관찰주사용혈전통연합포이린담감치료급성뇌경새적림상료효。방법：장120례급성뇌경새환자수궤분위2조，치료조60례，급여주사용혈전통500 mg가입0.9％록화납주사액250 mL，포이린담감0.75 g가입5％포도당주사액250 mL，정맥적주，1차/d，료정14천；대조조60례，급여포이린담감0.75 g가입5％포도당주사액250 mL，정맥적주，1차/d，료정14천。비교치료전、후증상개선급신경공능결손평분정황。결과：총유효솔치료조위96.00%，대조조위80.00%，2조비교차이유통계학의의(P＜0.05）。신경공능결손평분치료조개선교대조조명현(P＜0.05）。결론：주사용혈전통연합포이린담감주사액치료급성뇌경사림상료효현저。
To observe clinical efficacy ofXueShuanTonginjection combined with citicoline in the treatment of acute cerebral infarction. Methods: Totally 120 patients with acute cerebral infarction were randomly di-vided into the treatment group and the control group. 60 cases in the treatment group were givenXueShuanTongin-jection, 500 mg, plus 250 mL 0.9% sodium chloride injection, and 0.75 g citicoline plus 250 mL 5% glucose injec-tion, via intravenous injection (IV), once per day, for 14 days; 60 cases in the control group were given 0.75g citicol-ine plus 250 mL 5% glucose injection, via IV, once per day, for 14 days. The improvements of symptoms and neuro-logical severity score were compared before and after the treatment. Results: Total effective rate was 96.00% in the treatment group, and 80.00% in the control group, indicating a significant difference between two groups (P<0.05). The improvement of neurological severity score in the treatment group was more significant compared with that in the control group (P<0.05). Conclusion: The clinical efficacy ofXueShuanTonginjection combined with citicoline is significant in the treatment of acute cerebral infarction.